1. Home
  2. ACHV vs RMAX Comparison

ACHV vs RMAX Comparison

Compare ACHV & RMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACHV
  • RMAX
  • Stock Information
  • Founded
  • ACHV N/A
  • RMAX 1973
  • Country
  • ACHV United States
  • RMAX United States
  • Employees
  • ACHV N/A
  • RMAX N/A
  • Industry
  • ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • RMAX Real Estate
  • Sector
  • ACHV Health Care
  • RMAX Finance
  • Exchange
  • ACHV Nasdaq
  • RMAX Nasdaq
  • Market Cap
  • ACHV 167.6M
  • RMAX 187.5M
  • IPO Year
  • ACHV N/A
  • RMAX 2013
  • Fundamental
  • Price
  • ACHV $3.17
  • RMAX $8.42
  • Analyst Decision
  • ACHV Strong Buy
  • RMAX Hold
  • Analyst Count
  • ACHV 1
  • RMAX 1
  • Target Price
  • ACHV $12.00
  • RMAX $9.00
  • AVG Volume (30 Days)
  • ACHV 727.0K
  • RMAX 194.9K
  • Earning Date
  • ACHV 11-06-2025
  • RMAX 10-30-2025
  • Dividend Yield
  • ACHV N/A
  • RMAX N/A
  • EPS Growth
  • ACHV N/A
  • RMAX N/A
  • EPS
  • ACHV N/A
  • RMAX 0.48
  • Revenue
  • ACHV N/A
  • RMAX $298,162,000.00
  • Revenue This Year
  • ACHV N/A
  • RMAX N/A
  • Revenue Next Year
  • ACHV N/A
  • RMAX N/A
  • P/E Ratio
  • ACHV N/A
  • RMAX $17.53
  • Revenue Growth
  • ACHV N/A
  • RMAX N/A
  • 52 Week Low
  • ACHV $1.84
  • RMAX $6.90
  • 52 Week High
  • ACHV $5.31
  • RMAX $14.31
  • Technical
  • Relative Strength Index (RSI)
  • ACHV 51.96
  • RMAX 38.42
  • Support Level
  • ACHV $3.07
  • RMAX $8.33
  • Resistance Level
  • ACHV $3.48
  • RMAX $9.44
  • Average True Range (ATR)
  • ACHV 0.15
  • RMAX 0.28
  • MACD
  • ACHV -0.01
  • RMAX -0.16
  • Stochastic Oscillator
  • ACHV 34.85
  • RMAX 21.65

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

About RMAX RE/MAX Holdings Inc.

RE/MAX Holdings Inc operates as a franchisor of real estate brokerage services. It recruits and retains agents and sells franchises. The company's operating segments include Real Estate, Mortgage, Marketing Funds, and Others. It generates maximum revenue from the Real Estate segment.

Share on Social Networks: